Recently, lactoferrin has been suggested as a neuroprotective agent because the intranasal delivery of lactoferrin into AD mice can augment α-secretase-dependent APP processing through the ERK1/2-CREB and HIF-1α pathways [163]. This evidence concerns the gene HIF1A and Alzheimer disease.